- Company Directors - B
- Bauer John H
Insider Trading History of Bauer John H
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bauer John H since 2006.
The trader's CIK number is 1248055.
At the time of the last reporting, Bauer John H was the Director of Cti Biopharma Corp. (stock ticker symbol CTIC).
Also see all insider trading activities at Cti Biopharma Corp.
Note that in the past
BAUER JOHN H also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zones Inc (ZONS) by Bauer John H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ZONS | 0 | $0 | 0 | $0 | 67,500 | $186,967 |
| 2006 | ZONS | 0 | $0 | 0 | $0 | 7,500 | $50,025 |
Yearly summary of insider trading at Cti Biopharma Corp (CTIC) by Bauer John H
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | CTIC | 0 | $0 | 105,000 | $164,000 | 0 | $0 |
Insider trading activities at 2 companies by Bauer John H:
1. Zones Inc (ZONS)
2. Cti Biopharma Corp (CTIC)
Table 1. Insider trading of Zones Inc (ZONS) by Bauer John H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-12-30 | ZONS | Option Ex | 60,000 | 2.73 | 163,980 |
| 2008-04-30 | ZONS | Option Ex | 7,500 | 3.06 | 22,987 |
| 2006-02-28 | ZONS | Option Ex | 7,500 | 6.67 | 50,025 |
Table 2. Insider trading of Cti Biopharma Corp (CTIC) by Bauer John H
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-08-10 | CTIC | Sale | 80,000 | 1.50 | 120,000 |
| 2009-06-02 | CTIC | Sale | 25,000 | 1.76 | 44,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bauer John H
(Director of Cti Biopharma Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.